221 related articles for article (PubMed ID: 33224869)
1. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
Luo Q; Wang C; Peng B; Pu X; Cai L; Liao H; Chen K; Zhang C; Cheng Y; Pan M
Front Oncol; 2020; 10():1758. PubMed ID: 33224869
[No Abstract] [Full Text] [Related]
2. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
Front Oncol; 2022; 12():931140. PubMed ID: 36465354
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer.
Li Z; Fan L; Wu Y; Niu Y; Zhang X; Wang B; Yao Y; Chen C; Qi N; Wang DD; Lin PP; Tang D; Gao W
J Thorac Dis; 2022 May; 14(5):1544-1555. PubMed ID: 35693614
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy.
Qiu Y; Zhang X; Deng X; Zhang R; Cai Z; Zhang Z; Liu H
Eur J Surg Oncol; 2022 May; 48(5):1039-1045. PubMed ID: 34836729
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
Guan Y; Xu F; Tian J; Gao K; Wan Z; Wang Y; Gao M; Wang Z; Chong T
BMC Cancer; 2021 Jul; 21(1):826. PubMed ID: 34271857
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
7. Association of circulating tumor cell-white blood cell clusters with survival outcomes in patients with colorectal cancer after curative intent surgery.
Xu Y; Zhang Q; Xu Z; Xie Q; Ding W; Liu H; Deng H
BMC Gastroenterol; 2022 Dec; 22(1):503. PubMed ID: 36474175
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract][Full Text] [Related]
9. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.
Wang Y; Liu Y; Zhang Z; Lu B; Gao Y; Tong L; Hu M; Lin PP; Li B; Zhang T
BMC Cancer; 2023 Jun; 23(1):578. PubMed ID: 37349714
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma.
Wang C; Luo Q; Huang W; Zhang C; Liao H; Chen K; Pan M
Front Oncol; 2021; 11():686365. PubMed ID: 34178679
[TBL] [Abstract][Full Text] [Related]
11. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W
Front Oncol; 2021; 11():734564. PubMed ID: 34722281
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer.
Guan X; Li C; Li Y; Wang J; Yi Z; Liu B; Chen H; Xu J; Qian H; Xu B; Ma F
Front Oncol; 2021; 11():602222. PubMed ID: 34150608
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
15. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS
Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
18. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
Front Oncol; 2021; 11():601668. PubMed ID: 34123777
[TBL] [Abstract][Full Text] [Related]
19. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
Zhao L; Song J; Sun Y; Ju Q; Mu H; Dong X; Ding J; Liu Y; Wang X; Sun L; Wu J; Jiao Y; Lu S; Zhao X
Cancer Med; 2023 Jul; 12(13):13912-13927. PubMed ID: 37337648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
